| Title |
Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, February 2016
|
| DOI | 10.2147/ndt.s81549 |
| Pubmed ID | |
| Authors |
Amy E Williams, Julianne M Giust, William G Kronenberger, David W Dunn |
| Abstract |
Attention-deficit hyperactivity disorder (ADHD) has a prevalence rate of 7%-9% in the general population of children. However, in children with epilepsy, ADHD has been found to be present in 20%-50% of patients. This paper provides a review of ADHD prevalence in pediatric epilepsy populations and reviews data on specific symptom presentation and attention deficits in patients with epilepsy. This paper also reviews evidence-based treatments for ADHD and specifically the treatment of ADHD as a comorbid condition in children with epilepsy. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 33% |
| United Kingdom | 1 | 7% |
| Unknown | 9 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Practitioners (doctors, other healthcare professionals) | 3 | 20% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | <1% |
| Unknown | 158 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 24 | 15% |
| Other | 16 | 10% |
| Researcher | 16 | 10% |
| Student > Postgraduate | 16 | 10% |
| Student > Bachelor | 15 | 9% |
| Other | 33 | 21% |
| Unknown | 39 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 31% |
| Psychology | 19 | 12% |
| Neuroscience | 13 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
| Nursing and Health Professions | 6 | 4% |
| Other | 22 | 14% |
| Unknown | 42 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2023.
All research outputs
#1,536,716
of 25,654,806 outputs
Outputs from Neuropsychiatric Disease and Treatment
#198
of 3,142 outputs
Outputs of similar age
#26,665
of 408,021 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#8
of 71 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,142 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,021 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.